TY  - GEN
AU  - Long-Smith,Caitriona M
AU  - Manning,Sean
AU  - McClean,Paula L
AU  - Coakley,Meghan F
AU  - O'Halloran,Domhnall J
AU  - Holscher,Christian
AU  - O'Neill,Cora
TI  - The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease
SN  - 1559-1174
PY  - 2013///0829
KW  - Alzheimer Disease
KW  - genetics
KW  - Amyloid beta-Peptides
KW  - metabolism
KW  - Amyloid beta-Protein Precursor
KW  - Animals
KW  - Astrocytes
KW  - drug effects
KW  - Disease Models, Animal
KW  - Female
KW  - Frontal Lobe
KW  - pathology
KW  - Glucagon-Like Peptide 1
KW  - analogs & derivatives
KW  - Hypoglycemic Agents
KW  - pharmacology
KW  - Insulin Receptor Substrate Proteins
KW  - Insulin Resistance
KW  - Liraglutide
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Transgenic
KW  - Microglia
KW  - Mutation, Missense
KW  - Neuroprotective Agents
KW  - Phosphorylation
KW  - Plaque, Amyloid
KW  - prevention & control
KW  - Presenilin-1
KW  - Protein Processing, Post-Translational
KW  - Protein Transport
KW  - Receptor, Insulin
KW  - Signal Transduction
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s12017-012-8199-5
ER  -